UK markets closed

Ultragenyx Pharmaceutical Inc. (RARE)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
42.75-0.45 (-1.04%)
At close: 04:00PM EDT
43.58 +0.83 (+1.94%)
After hours: 05:20PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts17172019
Avg. Estimate-1.65-1.59-6.39-5.06
Low estimate-2.01-1.91-8.32-6.58
High estimate-1.36-1.25-4.71-2.33
Year ago EPS-2.25-2.23-8.25-6.39
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts15151919
Avg. Estimate124.91M131.17M513.95M630.04M
Low estimate120M121.9M501.5M559M
High estimate130.1M138.2M530.01M716.99M
Year ago sales108.31M98.05M434.25M513.95M
Sales growth (year/est)15.30%33.80%18.40%22.60%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-2.07-2.08-1.62-1.73
Actual EPS-2.25-2.23-1.52-2.03
Difference-0.18-0.150.1-0.3
Surprise %-8.70%-7.20%6.20%-17.30%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-1.65-1.59-6.39-5.06
7 days ago-1.64-1.59-6.45-5.04
30 days ago-1.63-1.58-6.44-4.96
60 days ago-1.63-1.58-6.45-4.9
90 days ago-1.61-1.51-6.29-4.36
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 days1113
Up last 30 days1124
Down last 7 daysN/AN/AN/AN/A
Down last 30 days1121
Growth estimatesRAREIndustrySector(s)S&P 500
Current qtr.26.70%N/AN/AN/A
Next qtr.28.70%N/AN/AN/A
Current year22.50%N/AN/AN/A
Next year20.80%N/AN/AN/A
Next 5 years (per annum)8.90%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A